UNSPSC 51141577: Ropizine

This classification denotes an anticonvulsant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q5128GW9D4. European Medicines Agency schedules Ropizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10383MIG. Ropizine generally arises in the molecular formula C24H26N4.

UNSPSC 51141577 Ropizine is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's request for information on direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance's generic pharmaceuticals and OTC products RFP—involve naloxone products, pharmacy benefit management infrastructure, and broad-spectrum generic drug supply chains respectively, none of which correspond to ropizine (a specific antihistamine compound). The code shows little relevant recent activity and appears to be a mislabeled or underutilized UNSPSC category in current state and local procurement.

The geographic spread of the three tagged opportunities spans Florida, Texas, and Minnesota, with the Minnesota solicitation explicitly serving multiple states including Oregon. However, because the opportunities do not actually procure ropizine, the geographic distribution does not reflect genuine demand for the product under this code. Business development professionals should verify that opportunities tagged with UNSPSC 51141577 genuinely require ropizine procurement before investing pursuit effort, as the current data suggests the code may not be the appropriate taxonomy assignment for active state and local pharmaceutical and medical device solicitations in these jurisdictions.